CClinicalTrials.gg
CompletedNCT04953182Updated Jul 7, 2021

Pain Modality Treatment After Hemorrhoidectomy

An observational study in Pain, Acute and Pain, Procedural, sponsored by Assuta Medical Center. Completed. Per ClinicalTrials.gov, last updated 2021-07-07.

Sponsored by Assuta Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,335
Sex
All
01

Study summary

Hemorrhoidectomy is one of the operations that causes the greatest intensity of pain. Treatment of postoperative pain is essential for the well-being of the patient. Long-term use of opioids and different drugs can have unintended consequences.

The objective is to corroborate which pain treatment modality is better in patients after hemorrhoidectomy.

Read the detailed description

Patients who have undergone a hemorrhoidectomy are included in the study, the pain treatment modality is conceived by the treating surgeon or anesthesiologist. The first modality is to administer pain killers on-demand depending on visual analog scales of pain and the second modality to give pain killers on determined hours.

02

Conditions studied

  • Pain, Acute
  • Pain, Procedural

Browse trials for

Keywords

  • Pain killers
03

In context

Pain, Procedural

237 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

This study's enrollment of 5,335 is above the median of 200 across 13 observational studies indexed under Pain, Procedural.

Browse Pain, Procedural studies →

Lead sponsor

Assuta Medical Center is the lead sponsor of 41 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients that underwent elective hemorrhoidectomy

Inclusion criteria

Elective surgery for hemorrhoids

Exclusion criteria

Exclusion Criteria:

Mental retardation Incapacitated patient Under 18 years old

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,335 participants (actual)
Patient registry
No

Groups and cohorts

  • Around the clock analgetic treatment

    Patients that underwent hemorrhoidectomy and pain killers are prescribed every specific hour independent of pain degree, if necessary drugs can be administered on demand.

    Other: Pain scale registry

  • On demand analgetic treatment

    A pain killers list is prescribed by the physician and the nurse decides which drug to administer depending on a protocol of treatment based on the visual analog scale.

    Other: Pain scale registry

Interventions

  • OtherPain scale registry

    The nurses ask the patient about the pain filling every two hours during the hospitalization.

06

What researchers measure

Primary outcomes

  1. Pain medition

    The pain registred is analyze as maximum, mean and on discharge.

    Time frame: Immediately after the intervention/procedure/surgery

  2. Drugs Administred

    The amount of drugs administred to each patients is analyzed

    Time frame: Immediately after the intervention/procedure/surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — The data will be sent to the accepting journal study

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04953182
Lead sponsor
Assuta Medical Center
Responsible party
Sergio Gabriel Susmallian (Head of the department of general surgery, Assuta Medical Center) — Principal investigator
First posted
Jul 7, 2021
Start date
Jul 1, 2016
Primary completion
Dec 31, 2020
Completion
May 30, 2021
Last update
Jul 7, 2021

Study contacts

Sergio G Susmallian, MD
principal investigator · Assuta Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion